Reviews & Book Chapters

1. Gealt, M. A., Shapiro, B. E., Lindley, T .A., and Evans, J. L. (1988) Sterol metabolism in Aspergillus species. In Aspergillosus and Aspergillosus (H. Van den Bossche, Ed.), pp. 135-145. Plenum, New York.

2. Gealt, M.A., Abdollahi, A., and Evans, J. L. (1989) Lipids and lipidal mycotoxins of fungi. Curr Topics Med Mycol 3:218-247.

3. Quistorff, B., Rømert, P., Evans J.L., and Witters, L.A. (1991) Digitonin perfusion in the study of metabolic zonation of the liver. In Regulation of Hepatic Function. Alfred Benzon Symposium 30 (N. Grunnet, B. Quistorff, Eds.), pp. 50-63. Munksgaard, Copenhagen.

4. Evans, J. L. (1998) Enhancement of insulin receptor signaling via inhibition of insulin receptor tyrosine phosophatase activity. In Cell Signal Tranaction: Implications for Drug Discovery. (S.A. Minden, P. Guttry, Eds.), pp. 123-146. IBC, Southborough.

5. Evans, J.L. and Jallal, B. (1999) Protein tyrosine phosphatases: their role in insulin action and potential as drug targets. Exp Opin Invest Drugs 8:139-160. (Invited review)

6. Evans, J.L. (1999) Alpha-lipoic acid for aging and diabetes: the benefits of extending plasma half-life. Anti-Aging Medical News 1:14-30. (Invited review)

7. Evans, J.L., and Goldfine, I.D. (2000) Alpha-lipoic acid: A multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes. Diabetes Technology and Therapeutics 2:401-413. (Invited review)

8. Evans, J.L., Goldfine, I.D., Maddux, B.A., and Grodsky, G.M. (2002) Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocrine Reviews 23:599-622.

9. Evans, J.L. and Rushakoff, R.J. (2002) Oral pharmacological agents for type 2 diabetes: sulfonylureas, meglitinides, thiazolidinediones, alpha-glucosidase inhibitors, and emerging approaches. Chapter 14. In EndoText.org: Carbohydrate metabolism and diabetes mellitus (I. D. Goldfine and R. J. Rushakoff, Section editors) (Invited chapter). Chapter updated in 2007; see publication #16 below.

10. Evans, J.L., Maddux, B.A., and Goldfine, I.D. (2003) Antioxidants in diabetic complications and insulin resistance. In Diabetes: From Research to Diagnosis and Treatment (I. Raz, J. Skyler, and E. Shafrir, Editors) Chapter 29. pp.479-496. Dunitz, London. (Invited chapter)

11. Evans, J.L., Goldfine, I.D., Maddux, B.A., and Grodsky, G.M. (2003) Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 52:1-8.

12. Evans, J.L. (2003) Diet, botanicals, and nutraceutical treatments for type 2 diabetes. Chapter 15. In EndoText.org: Carbohydrate metabolism and diabetes mellitus (I. D. Goldfine and R. J. Rushakoff, Section editors) (Invited chapter). Chapter updated in 2007; see publication # 18 below).

13. Evans, J.L., Youngren, J.F., and Goldfine, I.D. (2004) Effective approaches to treat insulin resistance: trim the fat and douse the fire. Trends Endocrinol Metabol 15:425-431. (Invited review)

14. Evans, J.L., Maddux, B.A., and Goldfine, I.D. (2005) The molecular basis for oxidative stress-induced insulin resistance. Antioxidants & Redox Signaling 7:1040-1052. (Invited review)

15. Evans, J.L., Lin, J.J., and Goldfine, I.D. (2005) Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPAR-alpha, PPAR-gamma, and PPAR-delta. Current Diabetes Reviews 1:299-307. (Invited review)

16. Evans, J.L. and Rushakoff, R.J. (2007) Oral pharmacological agents for type 2 diabetes: sulfonylureas, meglitinides, thiazolidinediones, alpha-glucosidase inhibitors, and emerging approaches. Chpater 14. In EndoText.org: Carbohydrate metabolism and diabetes mellitus (I. D. Goldfine and R. J. Rushakoff, Section editors) (Invited chapter) Accessed on-line at: http://www.mdtext.com/diabetes/diabetes16/diabetesframe16.htm

17. Evans, J.L. (2007) Antioxidants: Do the have a role in the treatment of insulin resistance? Indian J Med Res 125:353-370. (Invited review)

18. Evans, J.L. (2007) Non-pharmaceutical interventions for type 2 diabetes: nutrition, botanicals, antioxidants, minerals, and other dietary supplements. Chapter 15. In EndoText.org (Carbohydrate metabolism and diabetes mellitus (I. D. Goldfine and R. J. Rushakoff, Section editors) (Invited chapter). Accessed on-line at: http://www.mdtext.com/diabetes/diabetes13/diabetesframe15.htm

19. Evans, J. L. (2009) The Secret Life of Mitochondria. Medical Research Institute Press (Xymogen). San Francisco.

20. Evans, J. L. (2009) Pre-Clinical and clinical evidence for botanical interventions for type 2 diabetes. In Clinical Pharmocognosy: Therapeutic Validation and Product Quality. Mary Ann Liebert, New Rochelle. In press. (Invited Chapter).